<i>Notes from the Field:</i> Tetanus in an Unvaccinated Child — Oregon, 2017

Guzman-Cottrill, Judith A.; Lancioni, Christina; Eriksson, Carl; Cho, Yoon Jae; Liko, Juventila

doi:10.15585/mmwr.mm6809a3

Cited by 14 publications

(9 citation statements)

References 2 publications

(3 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Whitney et al ( 126 ) estimate that the costs of treating these diseases (i.e. hospitalizations) are about $17,000 and $100,000, respectively, although in 2017 the total costs of treating a single unvaccinated child for Tetanus could exceed $800,000 ( 127 ).…”

Section: Section 5: Actual Risks Costs and Benefits Of Vaccine Undementioning

confidence: 99%

Economic and Behavioral Influencers of Vaccination and Antimicrobial Use

Wagner

Prentice

Saad-Roy

et al. 2020

Front. Public Health

View full text Add to dashboard Cite

Despite vast improvements in global vaccination coverage during the last decade, there is a growing trend in vaccine hesitancy and/or refusal globally. This has implications for the acceptance and coverage of a potential vaccine against COVID-19. In the United States, the number of children exempt from vaccination for “philosophical belief-based” non-medical reasons increased in 12 of the 18 states that allowed this policy from 2009 to 2017 (1). Meanwhile, the overuse and misuse of antibiotics, especially in young children, have led to increasing rates of drug resistance that threaten our ability to treat infectious diseases. Vaccine hesitancy and antibiotic overuse exist side-by-side in the same population of young children, and it is unclear why one modality (antibiotics) is universally seen as safe and effective, while the other (vaccines) is seen as potentially hazardous by some. In this review, we consider the drivers shaping the use of vaccines and antibiotics in the context of three factors: individual incentives, risk perceptions, and social norms and group dynamics. We illustrate how these factors contribute to the societal and individual costs of vaccine underuse and antimicrobial overuse. Ultimately, we seek to understand these factors that are at the nexus of infectious disease epidemiology and social science to inform policy-making.

show abstract

Section: Section 5: Actual Risks Costs and Benefits Of Vaccine Undementioning

confidence: 99%

Economic and Behavioral Influencers of Vaccination and Antimicrobial Use

Wagner

Prentice

Saad-Roy

et al. 2020

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…The hospital case cost was 19.500 Euro (the care after discharge not included) that can be considered rather low in terms of medical costs of some other cases (6). However, it is still striking compared to the cost of the tetanus vaccine (5 Euro).…”

Section: Discussionmentioning

confidence: 98%

Unvaccinated child tetanus from nasal toy battery

Homola¹,

Klučka²,

Helešic³

et al. 2021

Cent Eur J Public Health

View full text Add to dashboard Cite

We present the case report of an unvaccinated Czech child with tetanus. The child had not received any vaccines due to its parent's refusal. The disease originated from the wound in the nose caused by a small flat battery. The typical onset of tetanus followed after two weeks, rapidly progressing to respiratory failure with the need for mechanic ventilation despite intensive treatment. The child spent five weeks in the hospital. Mild long-term sequelae persisted 5 months.

show abstract

“…In addition to the numerous morbidities during a prolonged PICU, the cost to treat a preventable disease is worth considering. A pediatric patient with generalized tetanus who needed 57 days of in-patient care had charges totaling $811,929 18 …”

Section: Discussionmentioning

confidence: 99%